1. 2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC). (September 2015) Authors: Embleton, A.C.; Perren, T.J.; Cook, A.; Kent, E.; Pfisterer, J.; Ledermann, J.A.; Pujade-Lauraine, E.; Kristensen, G.; Beale, P.; Cervantes, A.; Farrelly, L.; Kaplan, R.; Parmar, M. K.B.; Oza, A.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of Bioreactance and Echocardiographic Noninvasive Cardiac Output Monitoring and Myocardial Function Assessment in Primagravida Women. Issue 3 (September 2017) Authors: Doherty, A.; El-Khuffash, A.; Monteith, C.; McSweeney, L.; Breatnach, C.; Kent, E.; Tully, E.; Malone, F.; Thornton, P. Journal: Obstetric anesthesia digest Issue: Volume 37:Issue 3(2017:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP25.11: Rates of stillbirth and neonatal death secondary to IUGR over a 10‐year period. (September 2014) Authors: Nolan, C.; Kent, E. Journal: Ultrasound in obstetrics & gynecology Issue: Volume 44:Number 1(2014:Jul.) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗